Form 4: HealthEquity Executive Sells Shares

HealthEquity Inc. executive Delano Ladd reported a sale of 1,087 shares of common stock on July 8, 2026, for $95.08 per share.

Summary

• Delano Ladd, EVP, General Counsel at HealthEquity, Inc., sold 1,087 shares of common stock.
• The transaction occurred on July 8, 2026.
• The sale price was $95.08 per share.
• Following the transaction, Ladd beneficially owns 90,054 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the insider sale, but without further context on the executive's holdings or reasons for sale, a definitive negative sentiment is not warranted.

Negatives

• An executive sold a significant number of shares, which could be interpreted negatively by the market.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by senior executives, is a common event and can be driven by various personal financial planning reasons. However, significant or frequent sales can sometimes signal a lack of confidence in future stock performance.

Stakeholder Impact

• Shareholders may view the executive's sale as a potential negative signal, although the reasons for the sale are not disclosed.
• Employees may be influenced by executive trading activity, though this specific transaction is unlikely to have a direct impact.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Sale, Executive Compensation, Beneficial Ownership